-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on NovoCure, Raises Price Target to $17

Benzinga·05/04/2026 18:57:59
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains NovoCure (NASDAQ:NVCR) with a Equal-Weight and raises the price target from $13.5 to $17.